SCHEDULE 13G/AFiled May 13, 8:00 PM ET

Day One Biopharmaceuticals, Inc. SCHEDULE 13G/A

Atlas Venture Fund XI, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.